These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22085043)

  • 1. 'The study has taught me to be supportive of her': empowering women and involving men in microbicide research.
    Venables E; Stadler J
    Cult Health Sex; 2012; 14(2):181-94. PubMed ID: 22085043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of partnership dynamics in determining the acceptability of condoms and microbicides.
    Montgomery CM; Lees S; Stadler J; Morar NS; Ssali A; Mwanza B; Mntambo M; Phillip J; Watts C; Pool R
    AIDS Care; 2008 Jul; 20(6):733-40. PubMed ID: 18576176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
    Kelly CA; Friedland BA; Morar NS; Katzen LL; Ramjee G; Mokgatle MM; Ahmed K
    Cult Health Sex; 2015; 17(8):1004-20. PubMed ID: 25913101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
    Lanham M; Wilcher R; Montgomery ET; Pool R; Schuler S; Lenzi R; Friedland B
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19159. PubMed ID: 25224618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-framing microbicide acceptability: findings from the MDP301 trial.
    Montgomery CM; Gafos M; Lees S; Morar NS; Mweemba O; Ssali A; Stadler J; Pool R;
    Cult Health Sex; 2010 Aug; 12(6):649-62. PubMed ID: 20397079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Educating men about vaginal microbicides: considerations from Kenya.
    Gitome SW; Kwena ZA; Harper CC; Cohen CR; Bukusi EA
    Cult Health Sex; 2020 Jun; 22(6):660-674. PubMed ID: 31241426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
    Miller L; Morar N; Kapiga S; Ramjee G; Hayes R
    J Acquir Immune Defic Syndr; 2020 Dec; 85(4):458-465. PubMed ID: 33136745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
    AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
    J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya.
    Montandon M; Sahin-Hodoglugil NN; Bukusi E; Agot K; Boland B; Cohen CR
    Sex Health; 2008 Dec; 5(4):339-46. PubMed ID: 19061553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial.
    Hoffman S; Morrow KM; Mantell JE; Rosen RK; Carballo-Diéguez A; Gai F
    Arch Sex Behav; 2010 Jun; 39(3):748-60. PubMed ID: 19636696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa.
    Hartmann M; Palanee-Phillips T; O'Rourke S; Adewumi K; Tenza S; Mathebula F; Wagner D; Ayub A; Montgomery ET
    AIDS Care; 2019 Jun; 31(6):660-666. PubMed ID: 30309246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
    Vallely A; Fitzgerald L; Fiya V; Aeno H; Kelly A; Sauk J; Kupul M; Neo J; Millan J; Siba P; Kaldor JM
    BMC Res Notes; 2012 Nov; 5():613. PubMed ID: 23116431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young Women's use of a microbicide surrogate: the complex influence of relationship characteristics and perceived male partners' evaluations.
    Tanner AE; Fortenberry JD; Zimet GD; Reece M; Graham CA; Murray M
    Arch Sex Behav; 2010 Jun; 39(3):735-47. PubMed ID: 19224355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Men's attitudes towards a potential vaginal microbicide in Zimbabwe, Mexico and the USA.
    Coggins C; Blanchard K; Friedland B
    Reprod Health Matters; 2000 May; 8(15):132-41. PubMed ID: 11424261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's interest in vaginal microbicides.
    Darroch JE; Frost JJ
    Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical microbicides for prevention of sexually transmitted infections.
    Obiero J; Mwethera PG; Wiysonge CS
    Cochrane Database Syst Rev; 2012 Jun; (6):CD007961. PubMed ID: 22696373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbicide preference among young women in California.
    Holt BY; Morwitz VG; Ngo L; Harrison PF; Whaley KJ; Pettifor A; Nguyen AH
    J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in sexual behavior during a safety and feasibility trial of a microbicide/diaphragm combination: an integrated qualitative and quantitative analysis.
    Guest G; Johnson L; Burke H; Rain-Taljaard R; Severy L; von Mollendorf C; Van Damme L
    AIDS Educ Prev; 2007 Aug; 19(4):310-20. PubMed ID: 17685844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.
    Morrow K; Rosen R; Richter L; Emans A; Forbes A; Day J; Morar N; Maslankowski L; Profy AT; Kelly C; Abdool Karim SS; Mayer KH
    J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.